USA - engelsk - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - chlorpromazine hydrochloride (unii: 9wp59609j6) (chlorpromazine - unii:u42b7vya4p) - chlorpromazine hydrochloride 25 mg in 1 ml - for the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. do not use in patients with known hypersensitivity to phenothiazines. do not use in comatose states or in the presence of large amounts of central nervous system depressants (alcohol, barbiturates, narcotics, etc.).

USA - engelsk - NLM (National Library of Medicine)

physicians total care, inc. - chlorpromazine hydrochloride (unii: 9wp59609j6) (chlorpromazine - unii:u42b7vya4p) - chlorpromazine hydrochloride 25 mg - for the management of manifestations of psychotic disorders. for the treatment of schizophrenia. to control nausea and vomiting. for relief of restlessness and apprehension before surgery. for acute intermittent porphyria. as an adjunct in the treatment of tetanus. to control the manifestations of the manic type of manic-depressive illness. for relief of intractable hiccups. for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability and poor frustration tolerance. do not use in patients with known hypersensitivity to phenothiazines. do not use in comatose states or in the presence of large amounts of central nervous system depr

Malta - engelsk - Medicines Authority

wockhardt uk limited - levomepromazine hydrochloride - solution for injection - levomepromazine hydrochloride 25 mg/ml - psycholeptics

Malta - engelsk - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - levomepromazine hydrochloride - solution for injection - levomepromazine hydrochloride 25 mg/ml - psycholeptics

Malta - engelsk - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - chlorpromazine hydrochloride - film-coated tablet - chlorpromazine hydrochloride 25 mg - psycholeptics

Malta - engelsk - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - chlorpromazine hydrochloride - film-coated tablet - chlorpromazine hydrochloride 100 mg - psycholeptics

USA - engelsk - NLM (National Library of Medicine)

clipper distributing company, llc. - acepromazine maleate (unii: 37862hp2om) (acepromazine - unii:54ej303f0r) - acepromazine maleate 10 mg in 1 ml

Irland - engelsk - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - chlorpromazine hydrochloride - oral solution - 25 mg/5ml - phenothiazines with aliphatic side-chain; chlorpromazine

Canada - engelsk - Health Canada

sandoz canada incorporated - chlorpromazine (chlorpromazine hydrochloride) - solution - 25mg - chlorpromazine (chlorpromazine hydrochloride) 25mg - phenothiazines

USA - engelsk - NLM (National Library of Medicine)

tya pharmaceuticals - chlorpromazine hydrochloride (unii: 9wp59609j6) (chlorpromazine - unii:u42b7vya4p) - chlorpromazine hydrochloride 25 mg in 1 ml - for the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. do not use in patients with known hypersensitivity to phenothiazines. do not use in comatose states or in the presence of large amounts of central nervous system depressants (alcohol, barbiturates, narcotics, etc.).